Just after the ₹1.3 lakh crore Semicon 2.0 approval, attention is shifting beyond chip fabs. Here's how Indian fluorochemical ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

Economic asymmetry after cartridge introduction drives a design philosophy centered on minimizing false acceptances and protecting API, with >99.5% first-pass yield as the principal success criterion.

The global pharmaceutical packaging market is undergoing a significant transformation, driven by an escalating demand for secure, chemically inert, and high-precision containment solutions. Among the ...

Eupraxia Pharmaceuticals Inc. (“Eupraxia ” or the “Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

The S&P 500 fell on Thursday, as a slide in chip stocks weighed on the index even on the back of solid earnings.

Tuesday, July 14, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Chevron Corp.

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

The official urged requiring a fish farm to monitor for the tiny plastic particles. The E.P.A. said he had taken steps to ...

At the bustling exhibition halls of CPHI China, a premier global pharmaceutical and laboratory consumables trade show, international researchers and procurement managers gathered around a sleek, ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging ...

DoP calls for proposals for SMDI sub-scheme to set up common facilities for medical devices clusters: Gireesh Babu, New Delhi Wednesday, July 8, 2026, 08:00 Hrs [IST] The Departme ...